End TB Now (March 24, 2019)

According to WHO expert, Dr. Gundo Weiler, Tuberculosis (TB) is the third highest prevalence rate in the world, after South Africa and Lesotho. It is the number one killer among all infectious diseases, the world’s deadliest according to WHO. The Philippines is among the few countries where the number of people with TB continues to increase every year. More than 70 Filipinos lose their lives to TB everyday. Many of these patients develop drug resistant tuberculosis, which are more expensive and difficult to treat. This year’s World Tuberculosis (TB) Day theme is: “It’s time”. Global leaders are urged to keep the promises they made at the first-ever UN high-level meeting on TB in New York last September 2018. Secretary Duque, in New York, declared that he will focus on three game-changers: high level commitment, massive screening, testing and treatment, and mandatory notifications by the private sector. To wipe out TB, the Philippines is working hand-in hand with World Health Organization, the communities, the governments and other partner agencies. The clock is ticking. We cannot lose another day. No one should die of TB anymore. It’s time to find and treat the 2.5 million Filipinos with TB by 2022. #End TB Now! .

  • Tuberculosis (TB) remains to be one of the major causes of deaths worldwide. It is the leading killer of people living with Human Immunodeficiency Syndrome (HIV) and one of the principal causes of death relating to antimicrobial resistance.

TB and HIV

TB is one of the most important AIDS associated infectious disease worldwide; TB has become one of the leading causes of death among people with AIDS (WHO, 1994; Whalen et al, 1995; Vallop et al, 1999). TB and HIV are closely intertwined. HIV speeds up the spread of TB while TB is the leading cause of death among HIV/AIDS patients. TB among HIV/AIDS patients is unique in that while it is contagious, it is both readily treatable with standard drugs and potentially preventable (Raviglione et al, 1995). The early diagnosis and prompt management of TB among HIV patients may ensure longer life and reduced morbidity. Although patients with HIV-associated TB mostly have typical clinical pictures, the frequency of atypical manifestations is increased in states of advanced immunosuppression, thus making the diagnosis more difficult. .